President’s Letter | March 2021
From the Desk of Samantha Guild As you read this post, the U.S. and a lot of the world is…
Blog - Melanoma360
03/08/2021
President’s Letter | March 2021
From the Desk of Samantha Guild As you read this post, the U.S. and a lot of the world is…
|
03/08/2021
Donor Spotlight: Jeff Berg, Stage IV Melanoma Survivor
By Alicia Rowell, Vice President In 2008, Jeff Berg got news no one wants to hear. He was concerned…
|
|
03/08/2021
In Plain English: What are Acral Melanomas and How are They Similar to and Different from Common Cutaneous Melanomas?
By Kim Margolin, M.D. The definition of “acral” is “topmost” or “highest,” and this term refers to a body part…
|
03/08/2021
Melanoma By The State: Texas
Melanoma, don’t mess with Texas! That’s essentially the rallying cry of volunteers, medical institutions, foundations, and other interested groups…
|
03/08/2021
Survivor Spotlight: Acral Melanoma Survivor
Melanoma Can Hide in the Most Unlikely Places By Mara Klecker Lisa first noticed a pale band on her right…
|
02/23/2021
In Plain English—COVID-19, the vaccines, and melanoma: What do melanoma patients and their families need to know?
By Kim Margolin, M.D. Coronavirus is novel (new), and the vaccines are even newer, so little melanoma-specific information is…
|
02/23/2021
A Letter From Our Vice President | February 2021
From the Desk of Alicia Rowell, Vice President Hope, love, cure. That’s our theme this February, in honor of Valentine’s…
02/05/2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021| Source: PRNewswire Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa (“nemvaleukin”, formerly referred to as…
|
|
02/05/2021
“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation
Contact: Chris Miller (972) 788-2599 Publicity cjmiller@rainmakeradv.com (RICHARDSON, TEXAS) How do we honor the meaning of friendship and the potential…
|
|
02/05/2021
Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor
A Partner Through It All By Mara Klecker Mark Lewis was less than a year into his relationship when he…
|
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026